Showing 1 - 19 results of 19 for search 'Michael Piatak', query time: 0.03s Refine Results
  1. 1
    Distinct phenotype, longitudinal changes of numbers and cell-associated virus in blood dendritic cells in SIV-infected CD8-lymphocyte depleted macaques.

    Distinct phenotype, longitudinal changes of numbers and cell-associated virus in blood dendritic cells in SIV-infected CD8-lymphocyte depleted macaques. by Caroline Soulas, Patrick J Autissier, Tricia H Burdo, Michael Piatak, Jeffrey D Lifson, Kenneth C Williams

    Published 2015-01-01
    Get full text
    Article
    Save to List
    Saved in:
  2. 2
    AAV-Delivered Antibody Mediates Significant Protective Effects against SIVmac239 Challenge in the Absence of Neutralizing Activity.

    AAV-Delivered Antibody Mediates Significant Protective Effects against SIVmac239 Challenge in the Absence of Neutralizing Activity. by Sebastian P Fuchs, José M Martinez-Navio, Michael Piatak, Jeffrey D Lifson, Guangping Gao, Ronald C Desrosiers

    Published 2015-08-01
    Get full text
    Article
    Save to List
    Saved in:
  3. 3
    HSV-2 infection of dendritic cells amplifies a highly susceptible HIV-1 cell target.

    HSV-2 infection of dendritic cells amplifies a highly susceptible HIV-1 cell target. by Elena Martinelli, Hugo Tharinger, Ines Frank, James Arthos, Michael Piatak, Jeffrey D Lifson, James Blanchard, Agegnehu Gettie, Melissa Robbiani

    Published 2011-06-01
    Get full text
    Article
    Save to List
    Saved in:
  4. 4
    In vivo binding and retention of CD4-specific DARPin 57.2 in macaques.

    In vivo binding and retention of CD4-specific DARPin 57.2 in macaques. by Pavel Pugach, Anders Krarup, Agegnehu Gettie, Marcelo Kuroda, James Blanchard, Michael Piatak, Jeffrey D Lifson, Alexandra Trkola, Melissa Robbiani

    Published 2010-08-01
    Get full text
    Article
    Save to List
    Saved in:
  5. 5
    Effects of treatment with suppressive combination antiretroviral drug therapy and the histone deacetylase inhibitor suberoylanilide hydroxamic acid; (SAHA) on SIV-infected Chinese rhesus macaques.

    Effects of treatment with suppressive combination antiretroviral drug therapy and the histone deacetylase inhibitor suberoylanilide hydroxamic acid; (SAHA) on SIV-infected Chinese... by Binhua Ling, Michael Piatak, Linda Rogers, Ann-Marie Johnson, Kasi Russell-Lodrigue, Daria J Hazuda, Jeffrey D Lifson, Ronald S Veazey

    Published 2014-01-01
    Get full text
    Article
    Save to List
    Saved in:
  6. 6
    Persistence of viral reservoirs in multiple tissues after antiretroviral therapy suppression in a macaque RT-SHIV model.

    Persistence of viral reservoirs in multiple tissues after antiretroviral therapy suppression in a macaque RT-SHIV model. by Christopher Kline, Jean Ndjomou, Tamera Franks, Rebecca Kiser, Vicky Coalter, Jeremy Smedley, Michael Piatak, John W Mellors, Jeffrey D Lifson, Zandrea Ambrose

    Published 2013-01-01
    Get full text
    Article
    Save to List
    Saved in:
  7. 7
    HSV-2-driven increase in the expression of α4β7 correlates with increased susceptibility to vaginal SHIV(SF162P3) infection.

    HSV-2-driven increase in the expression of α4β7 correlates with increased susceptibility to vaginal SHIV(SF162P3) infection. by Diana Goode, Rosaline Truong, Guillermo Villegas, Giulia Calenda, Natalia Guerra-Perez, Michael Piatak, Jeffrey D Lifson, James Blanchard, Agegnehu Gettie, Melissa Robbiani, Elena Martinelli

    Published 2014-12-01
    Get full text
    Article
    Save to List
    Saved in:
  8. 8
    SIV vpx is essential for macrophage infection but not for development of AIDS.

    SIV vpx is essential for macrophage infection but not for development of AIDS. by Susan V Westmoreland, A Peter Converse, Kasia Hrecka, Mollie Hurley, Heather Knight, Michael Piatak, Jeffrey Lifson, Keith G Mansfield, Jacek Skowronski, Ronald C Desrosiers

    Published 2014-01-01
    Get full text
    Article
    Save to List
    Saved in:
  9. 9
    A tonsillar PolyICLC/AT-2 SIV therapeutic vaccine maintains low viremia following antiretroviral therapy cessation.

    A tonsillar PolyICLC/AT-2 SIV therapeutic vaccine maintains low viremia following antiretroviral therapy cessation. by Panagiotis Vagenas, Meropi Aravantinou, Vennansha G Williams, Edith Jasny, Michael Piatak, Jeffrey D Lifson, Andres M Salazar, James L Blanchard, Agegnehu Gettie, Melissa Robbiani

    Published 2010-09-01
    Get full text
    Article
    Save to List
    Saved in:
  10. 10
    PolyICLC Exerts Pro- and Anti-HIV Effects on the DC-T Cell Milieu In Vitro and In Vivo.

    PolyICLC Exerts Pro- and Anti-HIV Effects on the DC-T Cell Milieu In Vitro and In Vivo. by Meropi Aravantinou, Ines Frank, Magnus Hallor, Rachel Singer, Hugo Tharinger, Jessica Kenney, Agegnehu Gettie, Brooke Grasperge, James Blanchard, Andres Salazar, Michael Piatak, Jeffrey D Lifson, Melissa Robbiani, Nina Derby

    Published 2016-01-01
    Get full text
    Article
    Save to List
    Saved in:
  11. 11
    ADCC develops over time during persistent infection with live-attenuated SIV and is associated with complete protection against SIV(mac)251 challenge.

    ADCC develops over time during persistent infection with live-attenuated SIV and is associated with complete protection against SIV(mac)251 challenge. by Michael D Alpert, Jackson D Harvey, W Anderson Lauer, R Keith Reeves, Michael Piatak, Angela Carville, Keith G Mansfield, Jeffrey D Lifson, Wenjun Li, Ronald C Desrosiers, R Paul Johnson, David T Evans

    Published 2012-01-01
    Get full text
    Article
    Save to List
    Saved in:
  12. 12
    Efficacy of Carraguard-based microbicides in vivo despite variable in vitro activity.

    Efficacy of Carraguard-based microbicides in vivo despite variable in vitro activity. by Stuart G Turville, Meropi Aravantinou, Todd Miller, Jessica Kenney, Aaron Teitelbaum, Lieyu Hu, Anne Chudolij, Tom M Zydowsky, Michael Piatak, Julian W Bess, Jeffrey D Lifson, James Blanchard, Agegnehu Gettie, Melissa Robbiani

    Published 2008-09-01
    Get full text
    Article
    Save to List
    Saved in:
  13. 13
    Location and dynamics of the immunodominant CD8 T cell response to SIVΔnef immunization and SIVmac251 vaginal challenge.

    Location and dynamics of the immunodominant CD8 T cell response to SIVΔnef immunization and SIVmac251 vaginal challenge. by Arun K Sasikala-Appukuttan, Hyeon O Kim, Nikilyn J Kinzel, Jung Joo Hong, Anthony J Smith, Reece Wagstaff, Cavan Reilly, Michael Piatak, Jeffrey D Lifson, R Keith Reeves, R Paul Johnson, Ashley T Haase, Pamela J Skinner

    Published 2013-01-01
    Get full text
    Article
    Save to List
    Saved in:
  14. 14
    An antiretroviral/zinc combination gel provides 24 hours of complete protection against vaginal SHIV infection in macaques.

    An antiretroviral/zinc combination gel provides 24 hours of complete protection against vaginal SHIV infection in macaques. by Jessica Kenney, Meropi Aravantinou, Rachel Singer, Mayla Hsu, Aixa Rodriguez, Larisa Kizima, Ciby J Abraham, Radhika Menon, Samantha Seidor, Anne Chudolij, Agegnehu Gettie, James Blanchard, Jeffrey D Lifson, Michael Piatak, Jose A Fernández-Romero, Thomas M Zydowsky, Melissa Robbiani

    Published 2011-01-01
    Get full text
    Article
    Save to List
    Saved in:
  15. 15
    The immunologic effects of mesalamine in treated HIV-infected individuals with incomplete CD4+ T cell recovery: a randomized crossover trial.

    The immunologic effects of mesalamine in treated HIV-infected individuals with incomplete CD4+ T cell recovery: a randomized crossover trial. by Ma Somsouk, Richard M Dunham, Michelle Cohen, Rebecca Albright, Mohamed Abdel-Mohsen, Teri Liegler, Jeffrey Lifson, Michael Piatak, Robert Gorelick, Yong Huang, Yuaner Wu, Priscilla Y Hsue, Jeffrey N Martin, Steven G Deeks, Joseph M McCune, Peter W Hunt

    Published 2014-01-01
    Get full text
    Article
    Save to List
    Saved in:
  16. 16
    Persistent Low-Level Replication of SIVΔnef Drives Maturation of Antibody and CD8 T Cell Responses to Induce Protective Immunity against Vaginal SIV Infection.

    Persistent Low-Level Replication of SIVΔnef Drives Maturation of Antibody and CD8 T Cell Responses to Induce Protective Immunity against Vaginal SIV Infection. by Sama Adnan, R Keith Reeves, Jacqueline Gillis, Fay E Wong, Yi Yu, Jeremy V Camp, Qingsheng Li, Michelle Connole, Yuan Li, Michael Piatak, Jeffrey D Lifson, Wenjun Li, Brandon F Keele, Pamela A Kozlowski, Ronald C Desrosiers, Ashley T Haase, R Paul Johnson

    Published 2016-12-01
    Get full text
    Article
    Save to List
    Saved in:
  17. 17
    A MIV-150/zinc acetate gel inhibits SHIV-RT infection in macaque vaginal explants.

    A MIV-150/zinc acetate gel inhibits SHIV-RT infection in macaque vaginal explants. by Patrick Barnable, Giulia Calenda, Louise Ouattara, Agegnehu Gettie, James Blanchard, Ninochka Jean-Pierre, Larisa Kizima, Aixa Rodríguez, Ciby Abraham, Radhika Menon, Samantha Seidor, Michael L Cooney, Kevin D Roberts, Rhoda Sperling, Michael Piatak, Jeffrey D Lifson, Jose A Fernandez-Romero, Thomas M Zydowsky, Melissa Robbiani, Natalia Teleshova

    Published 2014-01-01
    Get full text
    Article
    Save to List
    Saved in:
  18. 18
    A potent combination microbicide that targets SHIV-RT, HSV-2 and HPV.

    A potent combination microbicide that targets SHIV-RT, HSV-2 and HPV. by Larisa Kizima, Aixa Rodríguez, Jessica Kenney, Nina Derby, Olga Mizenina, Radhika Menon, Samantha Seidor, Shimin Zhang, Keith Levendosky, Ninochka Jean-Pierre, Pavel Pugach, Guillermo Villegas, Brian E Ford, Agegnehu Gettie, James Blanchard, Michael Piatak, Jeffrey D Lifson, Gabriela Paglini, Natalia Teleshova, Thomas M Zydowsky, Melissa Robbiani, José A Fernández-Romero

    Published 2014-01-01
    Get full text
    Article
    Save to List
    Saved in:
  19. 19
    A cellular trafficking signal in the SIV envelope protein cytoplasmic domain is strongly selected for in pathogenic infection.

    A cellular trafficking signal in the SIV envelope protein cytoplasmic domain is strongly selected for in pathogenic infection. by Scott P Lawrence, Samra E Elser, Workineh Torben, Robert V Blair, Bapi Pahar, Pyone P Aye, Faith Schiro, Dawn Szeltner, Lara A Doyle-Meyers, Beth S Haggarty, Andrea P O Jordan, Josephine Romano, George J Leslie, Xavier Alvarez, David H O'Connor, Roger W Wiseman, Christine M Fennessey, Yuan Li, Michael Piatak, Jeffrey D Lifson, Celia C LaBranche, Andrew A Lackner, Brandon F Keele, Nicholas J Maness, Mark Marsh, James A Hoxie

    Published 2022-06-01
    Get full text
    Article
    Save to List
    Saved in:

Search Tools: